Cholesterol-lowering medication

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Humans1

Outcomes

3

Visual attention

downin humans1

1 study
  1. Cholesterol-lowering medication impairs visual attention in humans (0.393, 95%CI (0.120, 0.665)).

    “and a steeper decline of visual attention[0.393,(0.120,0.665)].”

    Humansurban population1 yearn = 518

    Association between serum lipid dysregulation, management, and cognitive decline in rural and urban Southern Indian population

    AAIC 2025 abstract23 Dec 2025

Memory

upin humans1

1 study
  1. Cholesterol-lowering medication improves memory in humans (immediate recall -0.369 (-0.642, -0.097), delayed recall -0.439 (-0.711, -0.166)).

    “and memory (immediate [‐0.369,(‐0.642,‐0.097)] and delayed [‐0.439, (‐0.711, ‐0.166)] recall) functioning”

    Humansurban population1 yearn = 518

    Association between serum lipid dysregulation, management, and cognitive decline in rural and urban Southern Indian population

    AAIC 2025 abstract23 Dec 2025

Language function

upin humans1

1 study
  1. Cholesterol-lowering medication improves language function in humans (-0.378, 95%CI (-0.649, -0.106)).

    “the use of cholesterol‐lowering medication was associated with a slower decline in language[‐0.378,(‐0.649,‐0.106)]”

    Humansurban population1 yearn = 518

    Association between serum lipid dysregulation, management, and cognitive decline in rural and urban Southern Indian population

    AAIC 2025 abstract23 Dec 2025

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months